Financials
- Market Capitalization 33.01 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
2.8
Relación precio/flujo de caja
0.88
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4396 | KYNB Kyntra Bio, Inc. - Common Stock | 8.33 USD | -1.88% | +5.18% | +17.99% | -12.41% | 33.73 M USD | ||
| 4401 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.39 USD | +1.46% | -17.26% | +24.11% | -65.93% | 33.38 M USD | ||
| 4420 | CNTX Context Therapeutics Inc. - Common Stock | 0.35 USD | -2.78% | -10.26% | -44.44% | -57.32% | 32.16 M USD | ||
| 4429 | BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.76 USD | +5.56% | +8.57% | +33.33% | -39.68% | 31.05 M USD |